SecBot SecBot

TECX

Tectonic Therapeutic, Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. NY· CIK 0001681087 Biotech & Drug Discovery
$20.07 −1.02 (−4.84%)
Oct 23 4:00 PM ET · prev $21.09
Market cap
$412.3M
Small cap
Consensus
Buy
93% Buy or better · 15 analysts
Median target
$76.00
+279% · range $26.00–93.00
Next earnings
Nov 5
in 10 days
1 year
+7.8%
from $18.62 · Oct 27
30 days
−14.6%
from $23.51
52-week range
$16.44–37.93
−47% from high · low Nov 5
Avg volume 20D
247.2K
Sep 29 spike 1.05M
Short interest
🔒 Subscribers only
Insider net
−$468.6K
2 buyers · 2 sellers · since Feb 4
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 5, 2026
Strongest NEUTRAL Former director Terrance McGuire filed a Form 144 notice to sell 10,200 shares of Tectonic Therapeutic…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B Feb 10 to Feb 11 2 days of insider buys: $182.4K by 2 insiders, avg $21.46
  • S Mar 3 to Mar 6 3 days of insider sells: $566.6K by 2 insiders, avg $28.96
  • S May 4 1 insider sell $31.9K at $30.00
  • S Jun 30 1 insider sell $6.0K at $35.00
  • S Aug 12 1 insider sell $1.5K at $35.00
  • S Aug 25 1 insider sell $1.6K at $36.52
  • S Sep 30 1 insider sell $12.3K at $23.04
  • A Oct 12 UBS initiates

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders bought $182.4K at an average $21.46. 2 insiders sold $651.0K. Price is 6% below their cost.

  • InstitutionsMIXED

    Q2 2026: 12 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    14 of 15 rate it Buy or better. Every target is above the price.

  • TrendDOWNTREND

    27% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
D. E. Shaw & Co., Inc.ADD186,550$6.4M
MARSHALL WACE, LLPTRIM172,101$5.9M
MILLENNIUM MANAGEMENT LLCDOUBLED165,525$5.7M
NORTHERN TRUST CORPADD113,904$3.9M
VANGUARD PORTFOLIO MANAGEMENT LLCADD94,414$3.2M
PRICE T ROWE ASSOCIATES INC /MD/TRIM48,001$1.7M
ExodusPoint Capital Management, LPTRIM35,239$1.2M
ALPS ADVISORS INCADD19,147$658.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 93% rate it Buy or better
Strong Buy6Buy8Hold1Sell0Strong Sell0
12-month targets · 9 analysts

Price is below the lowest target. Median implies +279%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 12, 2026UBS
INITIATE
INITIATENeutral
Aug 7, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
May 26, 2026Raymond James
UPGRADE
UPGRADEStrong Buy

Insider ledger

Form 4
$182.4K
bought · 2 insiders
$651.0K
sold · 2 insiders
−6.5%
vs their $21.46 cost
DateInsiderTypeValue
Sep 30, 2026
McNamara Peter
Chief Scientific Officer
SELL$12.3K
Sep 25, 2026
Lochner Daniel
Chief Financial Officer
TAX W/H$12.3K
Sep 25, 2026
McNamara Peter
Chief Scientific Officer
TAX W/H$10.5K
Sep 25, 2026
REICIN ALISE
Chief Executive Officer
TAX W/H$36.6K
Sep 25, 2026
Schwabish Marc
Chief Business Officer
TAX W/H$9.7K
Sep 25, 2026
Ruddy Marcella K.
Chief Medical Officer
TAX W/H$12.4K
Sep 3, 2026
Ruddy Marcella K.
Chief Medical Officer
AWARD24,250 sh
Sep 3, 2026
Lochner Daniel
Chief Financial Officer
AWARD24,250 sh

Earnings setup

Estimates
Nov 5
reports in 10 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Insider
McNamara Peter sold 536 shares
Chief Scientific Officer @ $23.04 ($12.3K)
Sep 25, 2026 Insider
Lochner Daniel surrendered for taxes 520 shares
Chief Financial Officer @ $23.67 ($12.3K)
Sep 25, 2026 Insider
McNamara Peter surrendered for taxes 444 shares
Chief Scientific Officer @ $23.67 ($10.5K)
Aug 21, 2026 SEC
Former director Terrance McGuire filed a Form 144 notice to sell 10,200 shares of Tectonic Therapeutic (TECX) valued…
144 — Impact 3/10
Aug 6, 2026 Earnings
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
WATERTOWN, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tect
Jun 30, 2026 Inst.
D. E. Shaw & — ADD
186,550 shares ($6.4M)
Jun 30, 2026 Inst.
MARSHALL WACE, LLP — TRIM
172,101 shares ($5.9M)
Jun 11, 2026 SEC
Six institutional investors accumulated $4.0M in TECX during Q3 2025, led by Point72 (+$2.0M) and Citadel (+$1.4M)…
INST-CLUSTER — Impact 4/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
TECX Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Aug 6, 2026
Earnings
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
WATERTOWN, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic” or the “Company”), a clinical stage…
Aug 5, 2026
Earnings date
TECX Q2 2026 Earnings Scheduled — 2026-08-05
Jun 10, 2026
Press release
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
WATERTOWN, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic” or the “Company”), a clinical stage…
May 7, 2026
Earnings
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
WATERTOWN, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic” or the “Company”), a clinical stage…
May 7, 2026
Earnings date
TECX Q1 2026 Earnings Scheduled — 2026-05-07

SecBot reports

8 filings · 1 bullish · 1 bearish · 6 neutral
All TECX filing & press-release reports (8)